Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis

Free Subscription 30.09.2019 1 Am J Epidemiol 1 Ann Intern Med 1 Arch Virol 1 Cancer 1 Gastroenterology 1 Hepatology 1 J Infect Dis 1 J Med Virol 2 Lancet Infect Dis 1 Nature 2 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Epidemiol

1. 
   RE: "SCALING UP HEPATITIS C PREVENTION AND TREATMENT INTERVENTIONS FOR ACHIEVING ELIMINATION IN THE UNITED STATES: A RURAL AND URBAN COMPARISON".
   Am J Epidemiol. 2019 Sep 25. pii: 5573751. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Ann Intern Med

2. GORDON CE, Berenguer MC, Doss W, Fabrizi F, et al
   Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
   Ann Intern Med. 2019 Sep 24. pii: 2751913. doi: 10.7326/M19-1539.
   PubMed     Text format     Abstract available
   
   

   
   Arch Virol

3. ZHOU K, Zhou Q, Yang D, Yue H, et al
   Hepatitis E virus in Tibetan pigs on the Qinghai-Tibetan Plateau: detection, molecular characterization and infection of BALB/c mice.
   Arch Virol. 2019 Sep 23. pii: 10.1007/s00705-019-04410.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

4. KIM NG, Nguyen PP, Dang H, Kumari R, et al
   Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
   Cancer. 2018 Apr 6. doi: 10.1002/cncr.31373.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

5. WIDJAJA AA, Singh BK, Adami E, Viswanathan S, et al
   Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis.
   Gastroenterology. 2019 May 8. pii: S0016-5085(19)40858.
   PubMed     Text format     Abstract available
   
   

   
   Hepatology

6. GOH MJ, Sinn DH, Kim S, Woo SY, et al
   Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
   Hepatology. 2019 Sep 25. doi: 10.1002/hep.30973.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

7. YANG HI, Yeh ML, Wong GL, Peng CY, et al
   REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.
   J Infect Dis. 2019 Sep 24. pii: 5573337. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Med Virol

8. ZHENG B, Zhang J, Zheng T, Wang H, et al
   ATP1B3 Cooperates with BST-2 to Promote Hepatitis B Virus Restriction.
   J Med Virol. 2019 Sep 26. doi: 10.1002/jmv.25599.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Infect Dis

9. ZALLER N, Ostrach B
   HCV, injection drug use, and the importance of harm reduction in Kenya.
   Lancet Infect Dis. 2019 Sep 17. pii: S1473-3099(19)30407.
   PubMed     Text format    
   
   
10. AKIYAMA MJ, Cleland CM, Lizcano JA, Cherutich P, et al
    Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Lancet Infect Dis. 2019 Sep 17. pii: S1473-3099(19)30264.
    PubMed     Text format     Abstract available
    
    

    
    Nature

11. REARDON S
    The US opioid epidemic is driving a spike in infectious diseases.
    Nature. 2019;571:15-16.
    PubMed     Text format    
    
    

    
    PLoS One

12. MANGIA A, Piazzolla V, Giannelli A, Visaggi E, et al
    Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.
    PLoS One. 2019;14:e0223287.
    PubMed     Text format     Abstract available
    
    
13. LONDONO MC, Riveiro-Barciela M, Ahumada A, Munoz-Gomez R, et al
    Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
    PLoS One. 2019;14:e0221567.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

14. GROOM HC, Smith N, Irving SA, Koppolu P, et al
    Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2019 Sep 20. pii: S0264-410X(19)31252.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: